CompletedPhase 1ketamine
Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)
Sponsored by Javelin Pharmaceuticals
NCT ID
NCT00662883
Target Enrollment
18 participants
Start Date
2007-11
Est. Completion
2008-02
About This Study
To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)
Conditions Studied
Interventions
- •PMI-150 (intranasal ketamine HCl); mometasone furoate
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria: * healthy adults * nonsmoker * no drug use Exclusion Criteria: * nasal abnormalities * airway abnormalities
Study Locations (1)
Baltimore, Maryland, United States